ICCM · CIK 0001584371 · FY2025 live · 2025-12-31
IceCure Medical Ltd.
View as
Model
Classic Z
FY2025
−13.69
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
6.82
0–100 · Classic Z tape · not a PD
Book standing
6
Year change
—
Market PD
—
O-score
9
Events on this name
Same published rows as Today. Not a live recompute.
MARKET PD UNAVAILABLE
watch · 41
- mertonPd: — → —
−13.69
Z″ −29.93
Score −13.69 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.561.2 × = 0.67X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−8.671.4 × = −12.14X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−1.093.3 × = −3.59X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
1.870.6 × = 1.12X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.241 × = 0.24
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
IceCure Medical Ltd. is on classic Z at −13.69 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 11th percentile in Healthcare.
- SKYEDistressSkye Bioscience, Inc.−13.77
- NXTCDistressNextCure, Inc.−13.78
- BMEADistressBiomea Fusion, Inc.−13.87
- CVDistressCapsoVision, Inc−13.46
- TLSIDistressTriSalus Life Sciences, Inc.−13.93
- SNTIDistressSenti Biosciences Holdings, Inc.−13.94
- EDITDistressEditas Medicine, Inc.−13.98
- ANVSDistressAnnovis Bio, Inc.−13.34
KPI widgets
Current assets
$13M
Total assets
$14M
Current liabilities
$5M
Total liabilities
$5M
Working capital
$8M
Retained earnings
−$120M
EBIT
−$15M
Total sales
$3M
Book equity
$9M
Accession 0001213900-26-028684. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.